Back to Search Start Over

LDL subclass lipidomics in atherogenic dyslipidemia: effect of statin therapy on bioactive lipids and dense LDL

Authors :
Peter J. Meikle
Patrice Thérond
Alexina Orsoni
Ricardo Tan
Philippe Giral
Paul Robillard
Anh Nguyen
M. John Chapman
Natalie A. Mellett
Service d’Endocrinologie, Métabolisme et Prévention des Risques Cardio-Vasculaires [CHU Pitié-Salpêtrière]
CHU Pitié-Salpêtrière [AP-HP]
Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
Service de Biochimie [AP-HP Hôpital Bicêtre]
AP-HP Hôpital Bicêtre (Le Kremlin-Bicêtre)
Baker Heart and Diabetes Institute (AUSTRALIA)
Unité de recherche sur les maladies cardiovasculaires et métaboliques, UMR S 1166
Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)
Source :
Journal of Lipid Research, Journal of Lipid Research, American Society for Biochemistry and Molecular Biology, 2020, 61 (6), pp.911-932. ⟨10.1194/jlr.P119000543⟩, Journal of Lipid Research, Vol 61, Iss 6, Pp 911-932 (2020), J Lipid Res
Publication Year :
2020
Publisher :
Elsevier BV, 2020.

Abstract

International audience; Atherogenic LDL particles are physicochemically and metabolically heterogeneous. Can bioactive lipid cargo differentiate LDLsubclasses, and thus potential atherogenicity? What is the effect of statin treatment? Obese hypertriglyceridemic hypercholesterolemicmales [n = 12; lipoprotein (a)

Subjects

Subjects :
Male
vsdLDL
GM3
0301 basic medicine
Apolipoprotein B
[SDV]Life Sciences [q-bio]
alkenylphosphatidylethanolamine
Lp-PLA2
030204 cardiovascular system & hematology
lysophosphatidylinositol
Biochemistry
trihexosylceramide
chemistry.chemical_compound
PC(O)
low density lipoprotein subclass heterogeneity
0302 clinical medicine
Endocrinology
Lp(a)
monosialodihexosylganglioside
Abbreviations: ASCVD
MetS
very small dense LDL
dhCer
small dense LDL
alkylphosphatidylcholine
Cer
biology
interleukin
isopycnic density gradient ultracentrifugation
Lipoprotein(a)
Middle Aged
[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism
alkenylphosphatidylcholine
CE
Lipoproteins, LDL
PC(P)
DHC
Low-density lipoprotein
cholesteryl ester
Lysophosphatidylinositol
LPI
Female
lipids (amino acids, peptides, and proteins)
atherosclerotic CVD
triacylglycerol
LPE
platelet-activating factor
medicine.medical_specialty
THC
LPC(O)
free cholesterol
cholesteryl ester transfer protein
monohexosylce- ramide
QD415-436
sdLDL
metabolic syndrome
alkylphosphatidylethanol- amine
pitavastatin calcium
lysophosphatidylcholine
PE(O)
dihydroceramide
03 medical and health sciences
Internal medicine
CETP
Cholesterylester transfer protein
Lipidomics
COH
medicine
Humans
ceramide
lipoprotein-associated phospholipase A2
Dyslipidemias
ceramides
Lipoprotein-associated phospholipase A2
lipoprotein (a)
PAF
IL
Cell Biology
Atherosclerosis
lysoalkylphosphatidylcholine
030104 developmental biology
dihexosylceramide
liquid chromatography electrospray ionization-tandem mass spectrometry
chemistry
TAG
PE(P)
biology.protein
Hydroxymethylglutaryl-CoA Reductase Inhibitors
MHC
Patient-Oriented and Epidemiological Research
low density lipoprotein
lysophosphatidylethanol- amine
Lipoprotein

Details

ISSN :
00222275
Volume :
61
Database :
OpenAIRE
Journal :
Journal of Lipid Research
Accession number :
edsair.doi.dedup.....20dd93e7908f9f2c79f931c73e4ffdf6